Psychiatry | Page 41 of 60 | Links Medicus Content Curation & Alerts in Medicine

ACMT Position Statement: Addressing Pediatric Cannabis Exposure

22 Apr, 2019 | 01:53h | UTC

ACMT Position Statement: Addressing Pediatric Cannabis Exposure – Journal of Medical Toxicology (free)

Study: Artificial Intelligence in Mental Health for Schizophrenia Prediction

20 Apr, 2019 | 13:40h | UTC

Towards artificial intelligence in mental health by improving schizophrenia prediction with multiple brain parcellation ensemble-learning – NPJ Schizophrenia (free)

Commentary: Improved AI-based tool increases accuracy of schizophrenia diagnosis – University of Alberta (free)

Cochrane Review: Nicotine Replacement for Smoking Cessation More Successful in Combination Form

19 Apr, 2019 | 08:42h | UTC

Different doses, durations and modes of delivery of nicotine replacement therapy for smoking cessation – Cochrane Library (free)

Commentaries: Nicotine replacement: when quitting cigarettes, consider using more nicotine, not less – The Conversation (free) AND Nicotine replacement therapy: new evidence on help to quit smoking – Evidently Cochrane (free) AND Nicotine replacement therapy more successful in combination form – Nuffield Department of Primary Care Health Sciences (free)

Related Commentary on Twitter

Featured Cochrane Review: Different doses, durations and modes of delivery of #nicotine replacement therapy for #smoking cessation from @CochraneTAG – Read comments from lead author https://t.co/WBvMA74iaK and the full review https://t.co/QFLx9Wb9Xc pic.twitter.com/tk2J6WRT3Z

— Cochrane (@cochranecollab) April 18, 2019

Meta-Analysis: Accuracy of Patient Health Questionnaire-9 (PHQ-9) for Screening to Detect Major Depression

19 Apr, 2019 | 08:39h | UTC

Accuracy of Patient Health Questionnaire-9 (PHQ-9) for screening to detect major depression: individual participant data meta-analysis – The BMJ (free)

Commentaries: The accuracy of the Patient Health Questionnaire-9 for detecting major depression – The BMJ Opinion (free) AND Screening tools for depression offer value when combined with an informed shared decision process – The BMJ Opinion (free) AND Using the Patient Health Questionnaire-9 to Screen for Major Depression – NEJM Journal Watch (free)

Randomized Trial: Smoking Cessation for People with Severe Mental Illness

18 Apr, 2019 | 07:50h | UTC

Smoking cessation for people with severe mental illness (SCIMITAR+): a pragmatic randomised controlled trial – The Lancet Psychiatry (free)

Commentaries: Smoking cessation in people with serious mental illness – The Lancet Psychiatry (free) AND New intervention doubles quit rate among smokers with severe mental illness – University of York (free) AND Smoking cessation for people with severe mental illness? “Oh yes they can!” SCIMITAR+ – The Mental Elf (free)

Sibling Controlled Cohort Study: Stress Related Disorders and Risk of Cardiovascular Disease

12 Apr, 2019 | 01:42h | UTC

Editorial: Stress, psychiatric disorders, and cardiovascular disease (free)

Commentaries: Stress-related disorders linked to heightened risk of cardiovascular disease – The BMJ (free) AND Stress from Traumatic Events Linked to Increased Risk of Heart Disease – MedicalResearch.com (free) AND Expert reaction to study looking at stress related disorders and risk of cardiovascular disease – Science Media Centre (free)

Related Commentary on Twitter

Stress related disorders–conditions triggered by a significant life event or trauma–may be linked to a heightened risk of cardiovascular disease (CVD), finds a large Swedish study published in @bmj_latest today https://t.co/01pyFcInu8 Linked editorial: https://t.co/vt7EWu4g9v pic.twitter.com/F9C77VJ9M2

— BMJ (@bmj_company) April 11, 2019

BMJ Review: Depression in Primary Care

9 Apr, 2019 | 02:11h | UTC

State of the Art Review: Depression in primary care: part 1—screening and diagnosis – The BMJ (free for a limited period)

Depression in primary care: part 2—management

Related Commentary on Twitter

#BMJInfographic Managing depression—this visual summary provides a guide to options for primary care. Click here to see the interactive version: https://t.co/6LpVKsMYxs @will_s_t pic.twitter.com/dZVsiwkNPF

— The BMJ (@bmj_latest) April 8, 2019

Study: Alcohol Consumption Uniformly Increases Blood Pressure and Stroke Risk

8 Apr, 2019 | 01:01h | UTC

Conventional and genetic evidence on alcohol and vascular disease aetiology: a prospective study of 500 000 men and women in China – The Lancet (free)

Commentaries: Unite for a Framework Convention for Alcohol Control – The Lancet (free) AND Even one alcoholic drink a day can raise risk of stroke, study says – CNN (free) AND Expert reaction to research on alcohol intake and stroke – Science Media Centre (free) AND Major study debunks myth that moderate drinking can be healthy – Reuters (free)

Related: Alcohol Use and Burden for 195 Countries and Territories (free study and commentaries) AND WHO Global Status Report on Alcohol and Health 2018 (free study and commentaries)

Meta-Analysis: Non-surgical Brain Stimulation for Major Depressive Episodes

29 Mar, 2019 | 07:49h | UTC

Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis – The BMJ (free)

Commentary: Consider non-surgical brain stimulation for severe depression, say experts – The BMJ (free)

Systematic Review: Adverse Effects of Pharmacological Treatments of Major Depression in Older Adults

29 Mar, 2019 | 07:45h | UTC

Systematic Review: Adverse Effects of Pharmacological Treatments of Major Depression in Older Adults – Agency for Healthcare Research and Quality (free)

See also: Full Report (free PDF) AND Evidence Summary (free PDF)

Guideline for the Diagnosis and Management of Work-related Mental Health Conditions in General Practice

27 Mar, 2019 | 06:19h | UTC

Clinical guideline for the diagnosis and management of work-related mental health conditions in general practice – National Health and Medical Research Council, Australian Government (NHMRC) (free PDF)

See also: Short Form Guideline (free PDF) AND GP Summary (free PDF)

Commentary: Managing work-related mental health conditions in family medicine – Canadian Medical Association Journal (free for a limited period)

Related Commentary on Twitter

New guidance aims to support family physicians to help patients whose mental illness arises in the workplace: https://t.co/LomlqKC61J #familymedicine #primarycare #mentalhealth pic.twitter.com/sFN6ji2EHg

— CMAJ (@CMAJ) March 26, 2019

Study: Electronic Versus Print Books in Parent-Toddler Interactions

26 Mar, 2019 | 01:35h | UTC

Differences in Parent-Toddler Interactions with Electronic Versus Print Books – Pediatrics (link to abstract – $ for full-text)

Commentaries: Does story time with an e-book change how parents and toddlers interact? – University of Michigan (free) AND Print Books Better Than E-Books for Parent-Toddler Interaction – NEJM Journal Watch (free) AND Reading to Your Toddler? Print Books Are Better Than Digital Ones – The New York Times (10 articles per month are free)

Study: Daily or High-Potency Cannabis Use Associated with Increased Incidence of Psychotic Disorder

21 Mar, 2019 | 06:36h | UTC

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study – The Lancet Psychiatry (free)

Commentaries: Cannabis and psychosis: triangulating the evidence – The Lancet Psychiatry (free) AND Expert reaction to daily cannabis use, potency and psychosis – Science Media Centre (free) AND Daily or high-potency cannabis increases risk of psychotic disorder, study finds – CNN (free) AND Daily cannabis and skunk users run higher psychosis risk – Reuters (free)

Large Observational Study Suggests Some Drugs for ADHD may Increase the Risk of Psychosis More than Others

21 Mar, 2019 | 06:32h | UTC

Psychosis with Methylphenidate or Amphetamine in Patients with ADHD – New England Journal of Medicine (link to abstract – $ for full-text)

Commentaries: Some ADHD medicines may increase psychosis more than others, ‘real-world’ data show – STAT (free) AND With ADHD, amphetamine has double the psychosis risk of methylphenidate – Reuters (free) AND Big data study identifies drugs that increase risk of psychosis in youth with ADHD – McLean Hospital (free)

Mental Health Issues Increased Significantly in Young Adults Over Last Decade

20 Mar, 2019 | 03:03h | UTC

Age, period, and cohort trends in mood disorder indicators and suicide-related outcomes in a nationally representative dataset, 2005–2017 – Journal of Abnormal Psychology (free PDF)

Commentaries: A Rise In Depression Among Teens And Young Adults Could Be Linked To Social Media Use – NPR (free) AND Mental health issues increased significantly in young adults over last decade – American Psychological Association (free)

Consensus Statement: Evaluation and Treatment of Agitated Children and Adolescents in the Emergency Department

20 Mar, 2019 | 03:06h | UTC

Best Practices for Evaluation and Treatment of Agitated Children and Adolescents (BETA) in the Emergency Department: Consensus Statement of the American Association for Emergency Psychiatry – West Journal of Emergency Medicine (free)

Brazilian Guidelines for the Management of Psychomotor Agitation

12 Mar, 2019 | 13:15h | UTC

Brazilian guidelines for the management of psychomotor agitation – Brazilian Journal of Psychiatry (free articles)

Part 1. Non-pharmacological approach

Part 2. Pharmacological approach

Guidelines for the Evaluation and Treatment of Perimenopausal Depression

11 Mar, 2019 | 12:02h | UTC

Guidelines for the Evaluation and Treatment of Perimenopausal Depression: Summary and Recommendations – Journal of Women’s Health (free)

Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia

11 Mar, 2019 | 11:44h | UTC

Clinical Guidance on the Identification and Management of Treatment-Resistant Schizophrenia – The Journal of Clinical Psychiatry (free)

FDA Approves Ketamine-like drug for Treatment-resistant Depression

7 Mar, 2019 | 12:44h | UTC

FDA approves new nasal spray medication for treatment-resistant depression; available only at a certified doctor’s office or clinic – U.S. Food & Drug Administration (free)

Commentaries: A ketamine-like drug is the first new antidepressant to get FDA approval in years: But it’s also controversial. – Vox (free) AND FDA Approves Intranasal Esketamine as Adjunctive Treatment for Depression – NEJM Journal Watch (free)

“But while some patient and doctor groups are hailing the approval, others aren’t so sure there’s enough evidence to justify it. That’s because the benefits of ketamine and esketamine aren’t yet well-understood. According to the FDA, the drug has only been studied in four clinical trials, three of them lasting just four weeks. And the results were pretty mixed.” (from Vox)

Related Commentary on Twitter

#FDA never learns from its past mistakes.
20 yrs ago, approved #Oxycontin, supposedly w restrictions.
We know how well those safety checks worked.
Now same blindness to risks of promoting #esketamine.
Doesnt it know people with #Depression will self medicate with street Special K https://t.co/FEj8S4QIFw

— Allen Frances (@AllenFrancesMD) March 6, 2019